Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.

Hoeks CM, Somford DM, van Oort IM, Vergunst H, Oddens JR, Smits GA, Roobol MJ, Bul M, Hambrock T, Witjes JA, Fütterer JJ, Hulsbergen-van de Kaa CA, Barentsz JO.

Invest Radiol. 2014 Mar;49(3):165-72. doi: 10.1097/RLI.0000000000000008.

PMID:
24220253
[PubMed - in process]
2.

Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.

Somford DM, Vreuls W, Jansen TS, van Basten JP, Vergunst H.

World J Urol. 2014 Apr;32(2):461-7. doi: 10.1007/s00345-013-1130-3. Epub 2013 Jul 20.

PMID:
23873356
[PubMed - in process]
3.

Alpha emitter radium-223 and survival in metastatic prostate cancer.

Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland ØS, Sartor O; ALSYMPCA Investigators.

N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755.

PMID:
23863050
[PubMed - indexed for MEDLINE]
Free Article
4.

The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.

Somford DM, Hamoen EH, Fütterer JJ, van Basten JP, Hulsbergen-van de Kaa CA, Vreuls W, van Oort IM, Vergunst H, Kiemeney LA, Barentsz JO, Witjes JA.

J Urol. 2013 Nov;190(5):1728-34. doi: 10.1016/j.juro.2013.05.021. Epub 2013 May 13.

PMID:
23680307
[PubMed - indexed for MEDLINE]
5.

Quality of life after prostate cancer treatments in patients comparable at baseline.

van Tol-Geerdink JJ, Leer JW, van Oort IM, van Lin EJ, Weijerman PC, Vergunst H, Witjes JA, Stalmeier PF.

Br J Cancer. 2013 May 14;108(9):1784-9. doi: 10.1038/bjc.2013.181. Epub 2013 Apr 23.

PMID:
23612450
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

MR imaging-guided focal cryoablation in patients with recurrent prostate cancer.

Bomers JG, Yakar D, Overduin CG, Sedelaar JP, Vergunst H, Barentsz JO, de Lange F, Fütterer JJ.

Radiology. 2013 Aug;268(2):451-60. doi: 10.1148/radiol.13121291. Epub 2013 Mar 22.

PMID:
23525206
[PubMed - indexed for MEDLINE]
7.

Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer.

Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA, Hambrock T, Fütterer JJ, Witjes JA, Bangma CH, Vergunst H, Smits GA, Oddens JR, van Oort IM, Barentsz JO; MR-PRIAS Collaboration Group.

Invest Radiol. 2013 Mar;48(3):152-7. doi: 10.1097/RLI.0b013e31827b711e.

PMID:
23328910
[PubMed - indexed for MEDLINE]
8.

Results of a phase 1 dose escalation study of intravesical TMX-101 in patients with nonmuscle invasive bladder cancer.

Falke J, Lammers RJ, Arentsen HC, Ravic M, Pozzi R, Cornel EB, Vergunst H, de Reijke TM, Witjes JA.

J Urol. 2013 Jun;189(6):2077-82. doi: 10.1016/j.juro.2012.11.150. Epub 2012 Nov 30.

PMID:
23206424
[PubMed - indexed for MEDLINE]
9.

Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.

Leyten GH, Hessels D, Jannink SA, Smit FP, de Jong H, Cornel EB, de Reijke TM, Vergunst H, Kil P, Knipscheer BC, van Oort IM, Mulders PF, Hulsbergen-van de Kaa CA, Schalken JA.

Eur Urol. 2014 Mar;65(3):534-42. doi: 10.1016/j.eururo.2012.11.014. Epub 2012 Nov 15.

PMID:
23201468
[PubMed - in process]
10.

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.

Bul M, Zhu X, Valdagni R, Pickles T, Kakehi Y, Rannikko A, Bjartell A, van der Schoot DK, Cornel EB, Conti GN, Boevé ER, Staerman F, Vis-Maters JJ, Vergunst H, Jaspars JJ, Strölin P, van Muilekom E, Schröder FH, Bangma CH, Roobol MJ.

Eur Urol. 2013 Apr;63(4):597-603. doi: 10.1016/j.eururo.2012.11.005. Epub 2012 Nov 12.

PMID:
23159452
[PubMed - indexed for MEDLINE]
11.

Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review.

Peters M, Moman MR, van der Poel HG, Vergunst H, de Jong IJ, Vijverberg PL, Battermann JJ, Horenblas S, van Vulpen M.

World J Urol. 2013 Apr;31(2):403-9. doi: 10.1007/s00345-012-0928-8. Epub 2012 Aug 18. Review.

PMID:
22903773
[PubMed - indexed for MEDLINE]
12.

Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.

van Tol-Geerdink JJ, Willem Leer J, Weijerman PC, van Oort IM, Vergunst H, van Lin EN, Alfred Witjes J, Stalmeier PF.

BJU Int. 2013 Apr;111(4):564-73. doi: 10.1111/j.1464-410X.2012.11402.x. Epub 2012 Aug 10.

PMID:
22882966
[PubMed - indexed for MEDLINE]
13.

Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.

Hoeks CM, Schouten MG, Bomers JG, Hoogendoorn SP, Hulsbergen-van de Kaa CA, Hambrock T, Vergunst H, Sedelaar JP, Fütterer JJ, Barentsz JO.

Eur Urol. 2012 Nov;62(5):902-9. doi: 10.1016/j.eururo.2012.01.047. Epub 2012 Feb 1.

PMID:
22325447
[PubMed - indexed for MEDLINE]
14.

Prognostic factors for survival in patients with recurrence of muscle invasive bladder cancer after treatment with curative intent.

Ploeg M, Kums AC, Aben KK, van Lin EN, Smits G, Vergunst H, Viddeleer AC, Geboers AD, van Berkel H, van Boven E, Kiemeney LA, Witjes F.

Clin Genitourin Cancer. 2011 Sep;9(1):14-21. doi: 10.1016/j.clgc.2011.05.004. Epub 2011 Jul 1.

PMID:
21723794
[PubMed - indexed for MEDLINE]
15.

Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy.

Cremers RG, van Lin EN, Gerrits WL, van Tol-Geerdink JJ, Kiemeney LA, Vergunst H, Smans AJ, Kaanders JH, Alfred Witjes J.

Radiother Oncol. 2010 Dec;97(3):467-73. doi: 10.1016/j.radonc.2010.05.023.

PMID:
20817287
[PubMed - indexed for MEDLINE]
16.

Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy.

Ploeg M, Kiemeney LA, Smits GA, Vergunst H, Viddeleer AC, Geboers AD, van Berkel H, van Boven E, Aben KK, Witjes JA.

Urol Oncol. 2012 May-Jun;30(3):247-51. doi: 10.1016/j.urolonc.2009.12.020. Epub 2010 May 6.

PMID:
20451418
[PubMed - indexed for MEDLINE]
17.

Effect of dutasteride on the risk of prostate cancer.

Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group.

N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127.

PMID:
20357281
[PubMed - indexed for MEDLINE]
Free Article
18.

Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.

Yakar D, Hambrock T, Huisman H, Hulsbergen-van de Kaa CA, van Lin E, Vergunst H, Hoeks CM, van Oort IM, Witjes JA, Barentsz JO, Fütterer JJ.

Invest Radiol. 2010 Mar;45(3):121-5. doi: 10.1097/RLI.0b013e3181c7bcda.

PMID:
20065860
[PubMed - indexed for MEDLINE]
19.

Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot study.

van Gils MP, Hessels D, Peelen WP, Vergunst H, Mulders PF, Schalken JA.

Prostate. 2009 Nov 1;69(15):1624-34. doi: 10.1002/pros.21011.

PMID:
19588525
[PubMed - indexed for MEDLINE]
20.

Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer.

Hendricksen K, van der Heijden AG, Cornel EB, Vergunst H, de Reijke TM, van Boven E, Smits GA, Puri R, Gruijs S, Witjes JA.

World J Urol. 2009 Jun;27(3):337-42. doi: 10.1007/s00345-009-0382-4. Epub 2009 Feb 13.

PMID:
19214526
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk